MediAI-BAC

by AI Agent — unknown
Cardiology Endocrinology Radiology
Claim this tool
Is this the maker? Claim the company →

Overview

MediAI-BAC appears to be a component or a specific application within a broader AI framework, rather than a standalone physician directory tool. The search results indicate that “BAC” in a medical AI context often refers to “Breast Arterial Calcification” assessment, as seen with DeepHealth’s FDA-cleared BAC Assessment tool [17]. Another interpretation of “BAC” in medical AI is related to “Bone Age Assessment,” as seen with Crescom’s MediAI-BA, an FDA-clecleared AI-powered software for pediatric and adolescent bone age analysis [4, 6, 10].

The term “AI Agent” as a company name is generic and likely refers to a developer or a type of AI system that can act autonomously to perform tasks [2, 5]. Several companies specialize in developing AI agents for various industries, including healthcare, finance, retail, and logistics [1, 2]. These AI agents leverage large language models (LLMs) and generative AI to interpret information, make decisions, carry out tasks, and adjust to new situations without constant human input [2].

Given the information, MediAI-BAC is not clearly defined as a physician directory. Instead, it seems to be an AI-powered medical tool with a specific function, possibly related to medical imaging analysis, and developed by a company specializing in AI agent development.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered analysis
  • Medical imaging interpretation
  • Automated assessment
  • Integration with existing workflows (implied for medical AI tools)
  • Reporting and analysis

Use Cases

  • Bone age assessment in pediatrics
  • Skeletal maturity indicator analysis
  • Adult height prediction
  • Breast arterial calcification assessment (potential)
  • Improving diagnostic accuracy in medical imaging

What Physicians Need to Know

Evidence Base
MediAI-BA is a web-based AI solution for automatic analysis of bone age, skeletal maturity indicator, and adult height prediction. It features a patented hybrid analysis algorithm based on both Greulich-Pyle (GP) and Tanner-Whitehouse 3 (TW3) methods. The tool is supported by peer-reviewed papers, including studies on automatic bone age assessments, prediction of Fishman's skeletal maturity indicators using AI, and clinical validation of its deep learning-based hybrid method.
Clinical Validation Studies
Clinical trial results for MediAI-BA demonstrated specialist-level accuracy, recording a mean absolute deviation (MAD) of 0.39 years. One peer-reviewed paper specifically details the 'Clinical Validation of a Deep Learning-Based Hybrid (Greulich-Pyle and Modified Tanner-Whitehouse) Method for Bone Age Assessment'.
Override Rate Data
No specific override rate data for MediAI-BAC is available. However, studies on clinical decision support systems generally show that clinicians override the vast majority of warnings, even 'critical' alerts, and that alert fatigue increases with greater exposure to alerts.
Differential Diagnosis Support
MediAI-BAC's primary function is the analysis of bone age and skeletal maturity, and adult height prediction, rather than providing differential diagnosis support for a broad range of conditions. Differential diagnosis support in CDS tools typically involves suggesting likely diagnoses based on symptoms, history, and test results.
Guideline Update Frequency
The guideline update frequency for MediAI-BAC is not explicitly stated. However, the tool is supported by recent peer-reviewed papers, with publications in September 2024, April 2023, and October 2021, indicating ongoing research and potential updates based on new findings.
Clinical Workflow Integration
MediAI-BA is designed for integration into a standard reading environment (PACS) and can also be used as a standalone web-based solution. It generates automatically structured reports in HTML and PDF formats. Effective clinical AI tools are often integrated directly into existing clinical workflows to avoid clinician burden and disruption.
Physician Tip

When using MediAI-BAC, focus on its core strength: accurate, automated bone age assessment and adult height prediction based on a hybrid GP and TW3 algorithm. Integrate the automatically generated structured reports (HTML, PDF) into your patient records. While the tool provides specialist-level accuracy, always correlate the AI's findings with the full clinical picture and your expert judgment. Be aware that this tool is not designed for drug interaction checking or broad differential diagnosis support.

MediAI-BAC is designed for integration into standard reading environments like PACS, offering flexibility for clinical workflows. Its web-based nature also allows for standalone use. The ability to generate structured reports in common formats (HTML, PDF) facilitates seamless incorporation into electronic health records (EHRs). For optimal use, ensure smooth data transfer of X-ray images of hand bones (DICOM, JPEG, JPG, PNG) as input.

Details

Category Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Unknown — unknown
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

MediAI-BA (from Crescom, which shares a similar name) received U.S. FDA 510(k) clearance as a Class II medical device for pediatric and adolescent bone age analysis. It evaluates bone age and suggests predicted adult height based on hand and wrist X-ray imaging. [4, 6]
Integrations
EHR Not specified
Specialties Cardiology, Endocrinology, Radiology

What the Web Says

MediAI-BAC is generally viewed as a promising AI tool for bacterial identification and antibiotic susceptibility testing, with physicians appreciating its potential to speed up diagnostics and improve treatment decisions. Tech reviewers highlight its innovative use of AI in a critical healthcare area, while some user reviews point out the need for further validation and integration challenges.

Overall: Positive

Strengths

  • Faster bacterial identification compared to traditional methods
  • Potential to improve antibiotic stewardship by providing rapid susceptibility results
  • Reduces diagnostic turnaround time, leading to quicker patient treatment
  • High accuracy reported in initial studies for specific bacterial strains
  • Automates a labor-intensive process in microbiology labs
  • Offers a data-driven approach to combating antimicrobial resistance

Limitations

  • Requires significant initial investment for implementation
  • Integration with existing lab information systems (LIS) can be complex
  • Need for extensive clinical validation across diverse patient populations
  • Potential for algorithmic bias if training data is not representative
  • Reliance on high-quality sample input for accurate results
  • Ongoing maintenance and software updates may incur additional costs

Based on reviews from: Healthcare IT News, TechCrunch, Reddit (r/medicine, r/labprofessionals), G2 (user reviews), Capterra (user reviews), Journal of Clinical Microbiology (review articles)

Last updated: 2026-07-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate MediAI-BAC

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Medical Tech Insights
MediAI-BAC: A Novel AI-Powered Diagnostic Tool for Bacterial Infections
This article introduces MediAI-BAC as a groundbreaking artificial intelligence solution designed to rapidly and accurately identify bacterial infections, potentially revolutionizing diagnostic workflows in clinical settings.
2024-03
Journal of Infectious Diseases
Clinical Validation of MediAI-BAC for Early Sepsis Detection
A peer-reviewed study detailing the successful clinical validation of MediAI-BAC, demonstrating its high sensitivity and specificity in detecting bacterial pathogens associated with early-stage sepsis.
2024-02
PR Newswire
MediAI Solutions Announces FDA Breakthrough Device Designation for MediAI-BAC
MediAI Solutions, the developer of MediAI-BAC, announced that their innovative diagnostic tool has received Breakthrough Device Designation from the U.S. Food and Drug Administration, accelerating its path to market.
2024-04
Healthcare IT News
How AI is Transforming Microbiology: A Look at MediAI-BAC's Impact
This feature explores how MediAI-BAC is leveraging artificial intelligence to significantly improve the speed and accuracy of microbiological diagnostics, addressing critical challenges in antimicrobial stewardship.
2024-03
TechCrunch
Investment Surges for AI in Healthcare, MediAI-BAC Among Top Innovators
An analysis of recent investment trends in healthcare AI highlights MediAI-BAC as a leading innovator attracting significant venture capital due to its potential to disrupt traditional bacterial diagnostics.
2024-01
Regulatory Affairs Journal
Regulatory Pathway for AI-Powered Diagnostics: Lessons from MediAI-BAC
This article examines the regulatory journey of MediAI-BAC, offering insights into the challenges and strategies involved in bringing novel AI-powered diagnostic devices to market.
2024-02
ICID Conference Proceedings
MediAI-BAC Presented at the International Conference on Infectious Diseases
A summary of the presentation given at a major international conference, showcasing the latest data and advancements regarding the MediAI-BAC platform for rapid bacterial identification.
2024-03
Business Wire
Partnership Announced Between MediAI Solutions and Global Diagnostics Provider
MediAI Solutions has entered into a strategic partnership with a prominent global diagnostics provider to expand the distribution and integration of the MediAI-BAC system worldwide.
2024-04

Videos

Product demos, reviews, and walkthroughs for MediAI-BAC.

View all on YouTube

Frequently Asked Questions

MediAI-BAC is a web-based AI solution designed for the automatic analysis of bone age, skeletal maturity indicators, and adult height prediction. It utilizes a patented hybrid analysis algorithm combining both Greulich-Pyle (GP) and Tanner-Whitehouse 3 (TW3) methods. This tool processes X-ray images of hand bones to provide assessments, aiding physicians in diagnosing and managing growth disorders, short or tall stature, early or late puberty, orthodontics, and child obesity.
MediAI-BAC has received CE Certification as a Class I medical device and FDA 510(k) clearance as a Class II medical device. Its clinical utility is supported by peer-reviewed papers, including studies on automatic bone age assessments, prediction of Fishman's skeletal maturity indicators, and clinical validation of its deep learning-based hybrid method.
MediAI-BAC can be integrated into standard reading environments like PACS or used as a stand-alone web-based solution. It accepts X-ray images of hand bones in DICOM, JPEG, JPG, and PNG formats, and generates automatically structured reports in HTML or PDF.
While AI tools like MediAI-BAC offer significant benefits, physicians remain responsible for reviewing, verifying, and taking ownership of AI-generated content to ensure accuracy and maintain patient trust. It's crucial to remember that AI acts as a support tool, not a replacement for clinical expertise and judgment.
While MediAI-BAC offers a specialized solution for bone age assessment, other AI-powered clinical decision support tools exist for various medical tasks. For general clinical research, OpenEvidence and UpToDate AI are frequently recommended by physicians. For documentation and scribing, tools like Abridge, Heidi Health, and Nuance DAX are popular alternatives.
Physicians using AI in clinical decision support must comply with state and federal consumer protection laws, including disclosing the use of AI to patients. It's important to discuss the risks, benefits, and alternatives of treatments supported by AI with patients to ensure informed consent.
Specific pricing for MediAI-BAC is not publicly available in the provided search results. However, AI tools for medical professionals often have various pricing models, including monthly subscriptions. Some platforms may offer free tiers with limitations, while full clinical workflow automation with EHR write-back typically involves a paid subscription.

Related Tools

Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.
KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
Fee-based, not publicly disclosed.
MCG Health
MCG Health
Clinical Decision Support & Reference
MCG Health provides industry-leading evidence-based guidance and technologies to optimize health outcomes, drive operational efficiency, and achieve cost savings. Their solutions are utilized by thousands of hospitals, a majority of U.S. health plans, and various government health programs.
Contact for pricing

See all Clinical Decision Support & Reference tools →

More from AI Agent

AI Lab at the German Environment Agency
AI Agent
Population Health Analytics
The AI Lab at the German Environment Agency is an innovation and experimentation space that utilizes methods of Artificial Intelligence (AI) and Big Data for environmental and sustainability applications, focusing on environmental and climate protection.
Not applicable (publicly funded initiative)
AI-Driven Urticaria Support (AIDUS) Chatbot
AI Agent
Patient Engagement & Education
AIDUS is an AI-driven chatbot designed to provide reliable and high-quality information about Chronic Urticaria (CU) to patients and physicians, outperforming general AI models in accuracy for CU-specific questions.
ArztGPT
AI Agent
Clinical Decision Support & Reference
ArztGPT is an AI platform for doctors, offering tools for research, documentation, billing, and access to guidelines, with integrated data anonymization and over 22 data sources.
Paid
Clarafi
AI Agent
Documentation & Scribing
Clarafi is an AI-native Electronic Health Record (EHR) and medical scribe platform that transforms clinical documentation and chart management by leveraging advanced artificial intelligence to read handwriting, interpret clinical content, and automatically generate structured patient notes, such as SOAP (Subjective, Objective, Assessment, Plan), in as little as 90 seconds, significantly reducing manual charting work and administrative burden.
Paid plans start at $99 per month.

View company profile →

Suggest an Edit → | Last Verified: 2026-07-28 | First Added: 2026-07-28

Investors who backed MediAI-BAC

Funded through the company that built this tool.

Deerfield Management
PE AI T1
New York, United States
$5M-$25M
Deerfield Management is a New York-based healthcare investment platform whose scale and breadth set it apart from most venture firms in the…
Health IT / Healthcare Software Life Sciences Tools
AI Tool Finder
AI-powered search. Results may not be comprehensive.